z-logo
open-access-imgOpen Access
To evaluate the safety and efficacy of saroglitazar among pre-diabetes and dyslipidemia
Author(s) -
Pravin G. Dhone,
Desabandhu Behera,
Vikas Gupta,
Mohd. Faheem Mubeen
Publication year - 2022
Publication title -
international journal of health sciences
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns2.8835
Subject(s) - prediabetes , dyslipidemia , medicine , diabetes mellitus , prospective cohort study , impaired fasting glucose , endocrinology , type 2 diabetes , impaired glucose tolerance

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom